Gadobenate Dimeglumine recalls
The FDA has published 2 recalls involving Gadobenate Dimeglumine since 2012. The latest was reported on 5 Sep 2012. Most were for packaging defects. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2012
Last 12 months0reported
Class I00% of total
Ongoing0latest 5 Sep 2012
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 50%Class III 1 50%
Why gadobenate dimeglumine is recalled
Companies
By year
All gadobenate dimeglumine recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Multihance Multipack (gadobenate dimeglumine) injection recalledMultihance | Bracco Diagnostics | Sterility | Nationwide |
| Drug | CLASS III | multihance (gadobenate dimeglumine) injection, 529 mg/mL recalledMultihance | Bracco Diagnostics | Packaging Defects | Nationwide |
Should you stop taking Gadobenate Dimeglumine?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.